New Supplier for X-ray and CT Components
Infineon Completes Acquisition of ams's Osram Sensor Portfolio
Infineon successfully acquired ams Osram’s non-optical analog/mixed-signal sensor portfolio effective July 1, 2026. Medical technology such as photon-counting detectors and interface ASICs, as well as position, temperature, and capacitive sensors, will now be manufactured by a different company.
The transaction for non-optical analog and mixed-signal sensors, announced in February 2026, has now been fully completed following the receipt of all regulatory approvals. With the purchase price of approximately 570 million euros, ams Osram is primarily reducing its debt and focusing its portfolio on opto-sensing technology.
With the closing of the deal, approximately 230 employees from research, development, and management will transfer to Infineon. As a result, the chip manufacturer is expanding its presence with three new locations in Valencia (Spain), Rapperswil (Switzerland), and Hyderabad (India). For the 2026 calendar year, Infineon expects revenue of approximately 230 million euros from the acquired business, which is expected to have an immediate positive impact on earnings per share.
X-ray Sensors for CT and Radiology
At the heart of the acquisition are the mixed-signal solutions for computed tomography and digital X-ray, as well as the associated sensor interface ASICs, which will continue to be developed under Infineon’s banner. It was already clear in February that, among other things, the key components for photon-counting detectors would continue to be produced on a “fabless” basis for Infineon at the remaining ams facility in Premstätten, Austria.
As previously announced, ams Osram will focus on optical vital signs monitoring going forward, so wearable developers should contact ams Osram in Regensburg for PPG sensors. Infineon, on the other hand, will take over non-optical sensor technology for radiology and industrial applications. Anyone in need of X-ray sensors for CT detectors will find what they need at the semiconductor company based in Neubiberg near Munich. The newly swapped portfolio is complemented by high-precision position, temperature, and capacitive sensors, which are relevant, among other things, for continuous glucose monitoring in diabetes patients.
Infineon Strengthens Its Medical Technology Business
For Infineon, the acquisition is more than just a portfolio addition—it gives the company, for the first time, a broad sensor base specifically for radiological imaging, which had previously been the domain of ams Osram.
"This acquisition is a perfect fit for Infineon's growth strategy in the sensors and radio frequency sectors," said Stephan Zizala, Division President of Edge Systems at Infineon.
The acquired teams will be integrated into the newly established Edge Systems Division, where Infineon combines sensor technology, computing power, connectivity, and security for edge applications—including medical edge applications in imaging.
Whether Infineon will actually translate its expanded capabilities—resulting from the combination of wafer technologies, mixed-signal IP, and the acquired medical technology expertise—into new product developments in the medical technology sector remains to be seen in the coming quarters. (uh)
